Literature DB >> 1327813

delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.

M Sofuoglu1, P S Portoghese, A E Takemori.   

Abstract

In this study we investigated the characteristics of binding sites with which delta opioid receptor agonists interact in homogenates of mouse brain using Krebs-HEPES medium. [3H][D- Ser2,Leu5,Thr6]enkephalin (DSLET), [3H][D-Ala2,D-Leu5]enkephalin (DADLE) and [3H][D-Pen2,D-Pen5]enkephalin (DPDPE) were used to label delta opioid binding sites. The analyses of the saturation binding data of these ligands (Scatchard plots) gave best fits to single rather than multiple site models. The binding capacity (Bmax) labelled by [3H]DSLET was found to be significantly greater than those of [3H]DADLE and [3H]DPDPE in brains of mice. Naltriben (the benzofuran analogue of naltrindole) was equally effective in competing for [3H]DSLET, [3H]DPDPE and [3H]DADLE binding sites. On the other hand, DADLE was significantly more potent in competing for [3H]DADLE and [3H]DPDPE binding sites than for [3H]DSLET binding sites. Also, DPDPE was more potent in competing for the binding sites of [3H]DADLE and [3H]DPDPE than for those of [3H]DSLET. DSLET was found to be equipotent in competing for [3H]DSLET, [3H]DPDPE and [3H]DADLE binding sites. These results suggest a heterogeneity of delta opioid receptors which may be explained possibly by the existence of delta opioid receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327813     DOI: 10.1016/0014-2999(92)90370-j

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptors.

Authors:  K D Wild; F Porreca; H I Yamamura; R B Raffa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

2.  Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.

Authors:  Julie E Pickett; Kunihiko Nagakura; Anna R Pasternak; Steven G Grinnell; Susruta Majumdar; Jason S Lewis; Gavril W Pasternak
Journal:  Bioorg Med Chem Lett       Date:  2013-06-06       Impact factor: 2.823

3.  Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice.

Authors:  H N Bharagava; G M Zhao
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 4.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

5.  Effect of delayed weaning on opioid receptor control of swim stress-induced antinociception in the developing rat.

Authors:  B Y Muhammad; I Kitchen
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

6.  Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.

Authors:  J Elliott; J R Traynor
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.